UK markets open in 5 hours 25 minutes

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
158.36-5.84 (-3.56%)
At close: 04:00PM EDT
162.46 +4.10 (+2.59%)
After hours: 07:09PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close164.20
Open159.00
Bid158.15 x 100
Ask158.70 x 300
Day's range152.25 - 164.06
52-week range110.45 - 211.13
Volume909,295
Avg. volume482,972
Market cap8.843B
Beta (5Y monthly)1.01
PE ratio (TTM)214.00
EPS (TTM)0.74
Earnings date31 Jul 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est204.62
  • GuruFocus.com

    Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment with Analyst Projections

    Detailed Analysis of Repligen's Financial Performance and Market Positioning

  • Zacks

    Repligen (RGEN) Misses Q1 Earnings Estimates

    Repligen (RGEN) delivered earnings and revenue surprises of -3.45% and 1.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Repligen Reports First Quarter 2024 Financial Results

    Reports first quarter revenue of $151 million Increased new modalities revenue by 16% year-over-yearIncreased Filtration (non-COVID) revenue by 12% year-over-yearAchieved a nine-month book-to-bill ratio of 1.03 WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter (Q1) of 2024, covering the three-month period ended March 31, 2024. The compa